International Assets Investment Management LLC purchased a new stake in Smith & Nephew plc (NYSE:SNN – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 24,663 shares of the medical equipment provider’s stock, valued at approximately $792,000.
Several other large investors have also recently bought and sold shares of SNN. Bank of Montreal Can boosted its holdings in Smith & Nephew by 355.8% in the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after purchasing an additional 964,762 shares during the period. Brandes Investment Partners LP boosted its holdings in Smith & Nephew by 20.5% in the 2nd quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after purchasing an additional 233,293 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after acquiring an additional 193,046 shares during the last quarter. Tocqueville Asset Management L.P. lifted its holdings in shares of Smith & Nephew by 294.9% during the 1st quarter. Tocqueville Asset Management L.P. now owns 224,441 shares of the medical equipment provider’s stock worth $5,692,000 after acquiring an additional 167,599 shares during the last quarter. Finally, Deprince Race & Zollo Inc. lifted its holdings in shares of Smith & Nephew by 94.2% during the 2nd quarter. Deprince Race & Zollo Inc. now owns 239,245 shares of the medical equipment provider’s stock worth $5,928,000 after acquiring an additional 116,078 shares during the last quarter. 25.64% of the stock is owned by institutional investors.
Smith & Nephew Price Performance
Smith & Nephew stock opened at $25.56 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The firm has a fifty day simple moving average of $29.75 and a two-hundred day simple moving average of $27.86. Smith & Nephew plc has a twelve month low of $23.65 and a twelve month high of $31.72.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Smith & Nephew
Smith & Nephew Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Featured Articles
- Five stocks we like better than Smith & Nephew
- What Are Dividend Contenders? Investing in Dividend Contenders
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Insider Buying Signals Upside for These 3 Stocks
- Most active stocks: Dollar volume vs share volume
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN – Free Report).
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.